Ocugen MALVERN, Pa., March 21, 2022 (World NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a scientific-stage biopharmaceutical enterprise concentrated on getting, developing, and commercializing gene therapies to treatment blindness health conditions and building a vaccine to help you save life from COVID-19, today introduced the appointment of Jessica Crespo, CPA, as […]
Friday, Oct 11, 2024
Breaking News